NYSE:WEI - Weidai Stock Price, Forecast & News

Weidai trades on the New York Stock Exchange (NYSE) under the ticker symbol "WEI."

Weidai is scheduled to release their next quarterly earnings announcement on Tuesday, March 24th 2020. View Earnings Estimates for Weidai.

1 equities research analysts have issued 12-month target prices for Weidai's shares. Their forecasts range from $5.40 to $5.40. On average, they expect Weidai's share price to reach $5.40 in the next twelve months. This suggests a possible upside of 97.1% from the stock's current price. View Analyst Price Targets for Weidai.

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Weidai in the last year. There are currently 1 sell rating for the stock, resulting in a consensus recommendation of "Sell." View Analyst Ratings for Weidai.

Media coverage about WEI stock has been trending positive this week, InfoTrie Sentiment reports. The research firm identifies negative and positive media coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Weidai earned a coverage optimism score of 3.0 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View News Stories for Weidai.

Some companies that are related to Weidai include Yirendai (YRD), Oportun Financial (OPRT), America First Multifamily Investors (ATAX), Curo Group (CURO), CNFinance (CNF), On Deck Capital (ONDK), Jiayin Group (JFIN), Wins Finance (WINS), X Financial (XYF), Elevate Credit (ELVT), Medallion Financial (MFIN), Security National Financial (SNFCA), Fincera (YUANF), Consumer Portfolio Services (CPSS) and Mogo Finance Technology (MOGO).

Based on aggregate information from My MarketBeat watchlists, some companies that other Weidai investors own include Netflix (NFLX), Voyager Therapeutics (VYGR), American Airlines Group (AAL), Amphastar Pharmaceuticals (AMPH), Ares Capital (ARCC), Baidu (BIDU), Avid Bioservices (CDMO), Chiasma (CHMA), Catalyst Pharmaceuticals (CPRX) and Corbus Pharmaceuticals (CRBP).

(WEI) raised $45 million in an initial public offering on Thursday, November 15th 2018. The company issued 4,500,000 shares at $9.00-$11.00 per share. Morgan Stanley and Citigroup served as the underwriters for the IPO and AMTD was co-manager.

Shares of WEI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of WEI stock can currently be purchased for approximately $2.74.

Weidai has a market capitalization of $193.02 million and generates $569.19 million in revenue each year. Weidai employs 9,919 workers across the globe.View Additional Information About Weidai.

The official website for Weidai is http://www.weidai.com.cn/.

Weidai's mailing address is 50F WEST BUILDING FORTUNE FINANCE CENTER NO.33 JIEFANG EAST ROAD JIANGGAN DISTRI, HANGZHOU F4, 310000. The company can be reached via phone at 86-185-0164-1666 or via email at [email protected]